Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:809-816

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galarza, C. R.
Right arrow Articles by Cámera, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galarza, C. R.
Right arrow Articles by Cámera, M. I.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Seniors' Health

(Hypertension. 1997;30:809-816.)
© 1997 American Heart Association, Inc.


Articles

Diastolic Pressure Underestimates Age-Related Hemodynamic Impairment

Carlos R. Galarza; José Alfie; Gabriel D. Waisman; Luis M. Mayorga; Luis A. Cámera; Miguel del Río; Federico Vasvari; Rodolfo Limansky; Jorge Farías; José Tessler; ; Mario I. Cámera

From the Unidad de Fisiología Clínica e Hipertensión Arterial, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires and Instituto de Investigaciones Clínicas and Mesa Nacional de Residentes de Clínica Médica, Sociedad Argentina de Medicina.

Correspondence to Dr Carlos R. Galarza, Unidad de Hipertensión Arterial, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Gascón 450 (1181), Buenos Aires, Argentina. E-mail galarza{at}connmed.com.ar


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract It has been hypothesized that as large arteries become more rigid with age, the pattern of hypertension changes from diastolic to systolic. Thus, diastolic blood pressure (DBP) may lose its ability to reflect the increase in vascular resistance with age. To assess this, we studied the age-related changes in blood pressure pattern and its steady-state and pulsatile determinants. We performed an epidemiological analysis based on a national survey of 10 462 subjects from Argentina. A hemodynamic analysis (impedance cardiography) was then carried out in 636 consecutive hypertensive patients (age, 25 to 74 years). Whereas the rate of increment in the prevalence of mild to moderate hypertension (MMH) reached a plateau after the sixth decade, isolated and borderline systolic forms of hypertension began a steep and sustained rise. Among patients with MMH, DBP remained stable from the third to the seventh decade, whereas SBP maintained a sustained increase. Despite similar DBP, the systemic vascular resistance index increased 47% (P<.01) and the cardiac index decreased 27% (P<.01), whereas the ratio of stroke volume to pulse pressure, an index of arterial compliance, decreased 45% (P<.01). However, there were no significant differences between older patients with MMH and those with isolated systolic hypertension in the level of SBP, vascular resistance, stroke volume, and cardiac index. Compared with age-matched normotensive control subjects, the ratio of stroke volume to pulse pressure was much more reduced in isolated systolic hypertension (48%) than in MMH (30%). In summary, the present study, carried out in a large sample of hypertensive subjects with a wide age range, showed a simultaneous impairment in vascular resistance and arterial compliance associated with aging in different patterns of hypertension. The magnitude of these changes, with opposite effects on DBP but additive effects on SBP, suggests that a hemodynamic mechanism could determine the transition in the prevalence of diastolic hypertension toward a systolic pattern of hypertension with aging. Also, the results suggest that SBP, but not DBP, is a reliable indicator of the underlying hemodynamic abnormalities (high resistance and low arterial compliance) in the elderly.


Key Words: hemodynamics • arterial compliance • blood pressure • hypertension, systolic • vascular resistance • age


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Conventionally, it has been assumed that high vascular resistance, the major hemodynamic abnormality in essential hypertension, is reflected by elevated DBP, whereas SBP is determined by SV and AC. However, the contribution of vascular resistance, CO, and AC for a given level of DBP and SBP varies from patient to patient, and the physiological significance of both pressures could change with aging. Epidemiological data show that SBP increases continuously with age, whereas DBP tends to decrease after the seventh decade. To explain this, it has been hypothesized that as large arteries become more rigid with aging, SBP will be higher and DBP lower for a given level of vascular resistance and blood flow.1 2 3 In a preliminary analysis in MMH, however, we observed that despite similar DBP, SVR and SBP showed a consistent rise with age.4 These data suggest that DBP may progressively lose its ability to reflect the age-related increase in vascular resistance, whereas SBP does not. Experimental data on animals showed that the effect of an isolated decrease in arterial compliance causes an increase in SBP as well as a decrease in DBP pressure of similar magnitude without a change in MAP. Therefore, although a decreased compliance may be found, this change alone cannot explain ISH.5 As a result, it would be expected that as the pattern of hypertension changes with age from diastolic to predominantly systolic, associated with a decrease in AC, an increase in vascular resistance takes place.

To assess this hypothesis and to gain insight concerning the change in BP pattern throughout the aging process in hypertensive subjects, we performed a cross-sectional epidemiological and hemodynamic study. The analysis included the steady state and pulsatile hemodynamic changes underlying the age-related transition in BP pattern and the hemodynamic differences between diastolic and isolated systolic forms of hypertension in older subjects.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Epidemiological Analysis
Epidemiological data were based on the Argentine Blood Pressure Study.6 A national sample of 10 462 noninstitutionalized subjects (age, 15 to 99 years) from the general population of 16 Argentine regions was studied during a 6-month period in 1990. BP was measured by physicians, with a standard aneroid sphygmomanometer, on two different days at an interval no greater than 1 week (three measurements each day). DBP was measured after Korotkoff's phase V. The average BP measurement was used to classify hypertension severity (in agreement with the Joint National Committee IV7 ).

Prevalence was adjusted by age and sex by taking into account the last population census. Subjects were grouped for decades beginning at 5 years (ie, first decade from 5 to 14 years).

We analyzed the (1) age-related trend in BP in the overall population, (2) age-related trends in BP in mild to moderate hypertensive and normotensive subjects, and (3) changes in MMH, BSH, and ISH prevalence with age.

Hemodynamic Analysis
After the completion of the epidemiological study, hemodynamic evaluations were performed in 636 consecutive hypertensive patients who were seen throughout a 2-year period. All subjects gave informed consent, and the study was approved by an institutional review committee. The procedures followed were in accordance with institutional guidelines. Patients were grouped as described below.

MMH Group
This group included 199 untreated mild to moderate hypertensive patients. The entry criteria included (1) no previous treatment of their hypertension or withdrawal from antihypertensive drugs at least 2 weeks (4 weeks in the case of diuretics) before the study, (2) DBP >89 and <115 mm Hg (six recordings averaged during two visits), (3) no use of sedative or hypnotic drugs, (4) no clinical or routine laboratory evidence of secondary causes of hypertension, (5) absence of any known condition that could invalidate the assessment of cardiac output by impedance cardiography (see "Methods"), (6) no clinical evidence of complicated hypertensive disease or other major illness, and (7) age range from 25 to 74 years.

Treated Group
Three hundred fifty-four treated hypertensive patients, irrespective of their current BP level, composed this group. The entry criteria adopted were the same as those in the MMH group, with the exception of items 1 and 2.

ISH Group
This group consisted of 32 ISH patients (SBP >159 mm Hg, DBP <90 mm Hg). With the exception of items 2 and 7, entry criteria were similar to those used for the MMH group. The entry criterion for age was 55 to 74 years.

BSH Group
Fifty-one borderline systolic hypertensive patients (SBP >139 and <160 mm Hg, DBP <90 mm Hg) composed this group. Entry criteria were similar to those used for the ISH group.

We analyzed age-related trends in steady state and pulsatile hemodynamic variables in untreated mild to moderate hypertensive patients and treated patients, and we compared hemodynamic variables among older patients with ISH, BSH, and MMH and normotensive subjects of similar age and same sex.

Procedures
All hemodynamic measurements were performed in basal conditions during the morning. After all recording devices were attached, patients rested for 15 minutes and then BP and impedance cardiography recordings were made three times.8

Cardiac output was measured by a Minnesota 304 B Impedance Cardiograph (Surcom Inc) by use of Kubicek's technique and equation.9 10 At the time of a short apnea after a passive expiration, avoiding Valsalva, simultaneous recordings of the first temporal derivative of impedance change during the cardiac cycle (dZ/dt) and phonocardiograms (Hewlett Packard 21050A transducer) were made with a recorder (model RG, Dyne) for manual measurement at a paper speed of 50 mm/s.9 10 11 12

The following formula was used to calculate ventricular SV in milliliters: SV={rho}(L/Z0)2 · T · (dZ/dt)max, where {rho} is electrical resistance of blood at 100 kHz13 ({Omega}/cm), L is mean distance between the inner electrodes (cm), Z0 is mean impedance of the thorax ({Omega}), (dZ/dt)max is peak value of the first derivative of thoracic impedance occurring during ventricular ejection ({Omega}/s), and T is ventricular ejection time (s).

Heart rate (HR, bpm) was obtained from the interbeat interval. CO was calculated as CO=SVxHR.

BP was determined by a mercury sphygmomanometer with the auscultatory method on the right brachial artery. Korotkoff's phase V was used as an indicator of DBP. MAP was calculated as DBP+(SBP-DBP)/3.

SVR was calculated by conventional formulas assuming a mean right atrial pressure of 4 mm Hg as SVR=[(MAP-4)/CO]x80, where 80 was used to convert the SVR from arbitrary units (mm Hg · L-1 · min-1) to the metric international system (dyne · s · cm-5).

SAC was estimated by the ratio of SV to PP (mL · mm Hg).14 15 16 17 18 19 20 Although this indicator of SAC depends on the BP at the end of diastole, it was possible to compare values obtained in groups with similar DBP values. The determination of the SV to PP ratio has shown a close correlation with other invasive and noninvasive techniques used to measure AC and has been used to estimate AC in population groups.15 16 17 18 19 20

Validation of Impedance Cardiography
Reliability of impedance cardiography for CO measurement has been questioned primarily because of concerns about the equation put forward by Kubicek et al9 rather than because of adverse results in selected populations. At present, a consensus is developing concerning the qualitative accuracy of this technique because of increased knowledge of the technique and its clinical limitations.10 11 12 13 21 22 In addition, before beginning this study, we observed and analyzed the tracings of impedance cardiography in different cardiovascular diseases in the catheterization laboratory for 2 years.21 We, as well as others, have verified that the method provides aberrant measurement of CO in several conditions, such as (1) cardiac diseases that modify blood flow directions during ventricular systole (valvular regurgitation or congenital shunts), (2) pathological thoracic conditions that modify the electric field of the thorax (pericardial or pleural effusion and hemopneumothorax), and (3) abnormal recordings of dZ/dt during ventricular systole (bicuspid wave).21 Therefore, excluding these conditions, several reports have shown that impedance cardiography is a reliable and reproducible method to estimate CO. The absolute value of CO determined by this method is usually higher than that of reference invasive methods.10 11 12 21 22 23 24 25 26 27 28 29 30 31 In our work, the correlation coefficient between simultaneous impedance cardiography and thermodilution determinations of CO in patients with coronary artery disease, severe hypertension, aortic stenosis, mitral stenosis, and congestive heart failure was .94, and the mean paired difference was 0.08 L/min (95% CI, -0.12 to 0.27 L/min). The regression equation for the two methods was y=-0.76+1.17x, where y=CO by impedance cardiography and x=CO by thermodilution.21 In our laboratory, the variation coefficient between two consecutive measurements of CO was 3.9%.30 In addition, we evaluated the long-term interassay variation of CO in 35 hypertensive patients (1-month interval). The mean paired difference was -0.05 L/min (95% CI, -0.16 to 0.05 L/min).31

Statistical Methods
Epidemiological Data
Statistical analysis of data from the survey was performed with an SAS program at the Cardiovascular Branch of the Centers for Disease Control and Prevention at Atlanta.

Hemodynamic Data
For statistical purposes, patients in the MMH group and treated MMH group were grouped by decades in the same way as the subjects in the survey. Results were expressed as mean±SD. Comparisons were made by a one-way ANOVA. When statistically significant differences were found, multiple comparisons were performed by Bonferroni's t test.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Epidemiological Findings
When the entire population (n=10 462) was analyzed, both DBP and SBP rose progressively with age until the sixth decade. Then, the SBP continued a sustained and progressive increase, whereas DBP reached a plateau and even decreased slightly after the seventh decade (Fig 1ADown).



View larger version (13K):
[in this window]
[in a new window]
 
Figure 1. A, Trend in BP with age in the overall population from Argentine Blood Pressure Study (n=10 462 subjects). B, Trends in BP with age in mild to moderate hypertensive and normotensive subjects (NT) of the same survey.

However, when mild to moderate hypertensive subjects (n=1561) were analyzed separately (Fig 1BUp), the mean DBP remained stable (93 to 97 mm Hg) throughout the age range, whereas the SBP increased a mean of 24 mm Hg from the 25th through the 34th year to the 65th through the 74th year, reaching levels similar to those observed in ISH patients of similar age. Normotensive subjects experienced a similar age-related tendency in their BP profile with a smaller increase in SBP (7 mm Hg) throughout the five decades (Fig 1BUp).

Hypertension prevalence increased in a sustained and progressive way throughout the range of ages (Fig 2Down). The MMH prevalence increased substantially until the sixth decade, after which a significant decrease took place in the following decades. In contrast, ISH and BSH prevalence experienced a steep rise after the sixth decade.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 2. Prevalence by age of different subgroups of hypertension pattern (JNC IV criteria) in Argentina. The rate of increase in prevalence of diastolic (MMH) and systolic pattern (ISH and BSH) with respect to the preceding decade demonstrated an opposite trend.

Hemodynamic Results
Systemic Hemodynamics and Age in the MMH Group
Anthropometric variables of MMH and sex were similar among the five decades. Mean DBP was similar over the five decades (range, 94±5 to 96±5 mm Hg), whereas mean SBP rose significantly (19%, P<.05). There was a mild and nonsignificant rise in MAP (Table 1Down). The SVRI increased 47% (P<.01) and CI decreased 27% (P<.01) from the third decade (25 to 34 years) to the seventh decade (65 to 74 years).


View this table:
[in this window]
[in a new window]
 
Table 1. Hemodynamic Variables in Untreated Mild to Moderate Hypertension (n=199)

The ratio of SV to PP decreased 45% (P<.01) from the third to the seventh decade (Fig 3Down). There was a mild and nonsignificant decrease in stroke index and HR (7%).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. Trend in BP and the principal hemodynamic variables with age. CI is expressed as L · min-1 · m2; SVRI as dyne · s · cm-5 · m2 · 1000; SV/PP systemic arterial compliance index as mL/mm Hg; and SBP and DBP as mm Hg.

Systemic Hemodynamics and Age in Treated Patients
These patients were under treatment with ACE inhibitors (n=224), calcium channel blockers (n=89), ß-blockers (n=65), diuretics (n=37), and other drugs (n=17). The trends in BP and hemodynamic variables with age were similar to the untreated mild to moderate hypertensive patients (Table 2Down). Diastolic BP did not change significantly with age (range, 82±12 to 91±12 mm Hg), whereas mean SBP rose significantly (27%) throughout the 5 decades. In addition, SVRI increased 58% (P<.05) and mean CI decreased 37% (P<.05) with a mild and nonsignificant rise in MAP over the third to seventh decade. The mean ratio of SV to PP decreased 52% (P<.05) over the five decades.


View this table:
[in this window]
[in a new window]
 
Table 2. Hemodynamic Variables in Treated Hypertensive Subjects (n=354)

Hemodynamic Difference Between Systolic (BSH and ISH) and Diastolic (MMH) Patterns of Hypertension
Whereas ISH and BSH are more common after the sixth decade of life, the hemodynamic analysis was confined to the 55- to 74-year age range (Table 3Down). Compared with normotensive control subjects, the three hypertensive groups had higher SVRI (48% in MMH, 35% in ISH, and 30% in BSH; P<.05) and lower ratios of SV to PP (30% in MMH, 48% in ISH, and 34% in BSH; P<.05). However, the CI was similar among the four groups.


View this table:
[in this window]
[in a new window]
 
Table 3. Hemodynamics of Isolated and Borderline Systolic Hypertensive Subjects vs Mild to Moderate Hypertensive and Normotensive Subjects (Aged 55 to 74 y)

Compared with MMH, ISH showed a lower ratio of SV to PP (25%, P<.05), whereas BSH showed an intermediate value. SVRI was lower in BSH than in MMH, and the difference did not attain statistical significance in the ISH group (ANOVA and t test).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In these studies, we combined epidemiological and hemodynamic data to learn more about the hemodynamic changes that underlie age-related BP patterns. As in previous studies performed in other occidental countries, data from the present survey showed that the prevalence of MMH increased with age and reached a plateau beyond the sixth decade.6 32 In contrast, the prevalence of ISH showed a steep rise in elderly people. In addition to the increased prevalence of systolic subtypes of hypertension, diastolic hypertension demonstrates a transition toward a disproportionate systolic pattern with aging. After the sixth decade, the MMH pattern exhibits SBP levels in the range seen in ISH.

The age-related change in steady state and pulsatile in hemodynamic determinants of BP reported here agrees with previous results.33 34 35 36 The primary value of this study is the measurement of the concurrent changes in steady-state as well as pulsatile hemodynamic parameters among hypertensive subjects with similar DBP over a wide age range (25 to 75 years). In untreated patients with MMH, SVR increased 47% from the third to the seventh decades despite similar DBP. This hemodynamic phenomenon could be explained by the concurrent decrease in both CO and AC (27% and 45%, respectively). In contrast, SBP increased on average from 143 to 170 mm Hg, reaching a level comparable to that of ISH. A similar trend was observed in treated hypertensive subjects and in the BP survey.

In addition, our older patients with isolated systolic and borderline systolic hypertension showed 35% and 30% higher SVR and 48% and 34% lower AC (the ratio of SV to PP), respectively, compared with age-matched normotensive control subjects. Interestingly, there was no significant difference in the level of SVR between older patients with MMH and those with ISH despite the normal DBP level in the latter group.

The contribution of low AC to ISH pattern has been demonstrated by Simon et al.37 This study confirms that both high SVR and low AC are common features of hypertension in the elderly, either with the diastolic or the isolated systolic form. Also, our results performed in a large population of systolic hypertension (ISH and BSH) confirm previous invasive studies based on smaller samples comparing ISH and normal subjects.38

The hemodynamic data described above are consistent with results obtained with circulation models. These models provide experimental evidence about the effect of isolated changes in a given hemodynamic parameter on systolic and diastolic BP.5 18 19 34 35 36 37 38 39 40 41 Using closed-chest animals, Randall et al showed the effect of isolated changes in AC. Whereas decreased AC caused an increase in systolic pressure and a decrease in diastolic pressure by the same magnitude, the effect on mean pressure was minimal. A significant decrease in CO occurred only when the decrease in compliance was large.5 Based on an electrical model of circulation, Berger and Li39 estimated that under constant flow, the vascular change needed to obtain DBP and SBP levels in the range of ISH could be obtained with a 25% rise in SVR combined with a 50% to 75% reduction in SAC. According to our data, we can speculate that after 4 decades, a young patient with MMH would experience a 19% fall in CI associated with a 36% increase in SVR and a 45% decrease in SAC, remaining within the same DBP range. However, a pattern of ISH could be reached with a 23% increase in SVRI and a 55% decrease in the ratio of SV to PP.

Thus, a reduction in AC with age may offset the predicted effect of the SVR increment on the DBP.5 18 19 39 40 41 The latter, though generally known, is not considered frequently by physicians. In contrast, both the rise in vascular resistance and the reduction in AC have an additive effect on SBP.

Although the increase in SBP, which is included in the computation of SVR through MAP, could exaggerate the increase in SVR, the change in vascular resistance in 78% of mild to moderate hypertensive patients over the 5 decades is attributable to a decrease in systemic blood flow. Only the remaining percentage (22%) can be attributed to a mild, though not a significant, increase in MAP, which is related to the rise in SBP. Furthermore, recent studies support the hypothesis that PP may be one of the major determinants of the structural changes in small vessels during long-term hypertension.43 44 James et al44 showed a significant relation between the media-lumen ratio and the PP independently of the age, MAP, and BP variability in a group of untreated elderly subjects, most of whom were hypertensive. Therefore, the rise in SVR could be the result of structural adaptive changes of resistance of vessels to the high PP. It is also likely that in the presence of low AC and wide PP, SVR may increase to maintain a constant flow in peripheral circulation.

Other possible limitations of the present study are the assumed value of the right atrial pressure and the determination of PP from the humeral artery. Even though a mild pulmonary arterial pressure increases with age in hypertensive patients, the use of a constant value for right atrial pressure in the calculation of SVR should attenuate slightly the observed age-related increase in SVR.42 As underscored by O'Rourke et al,45 there is a progressive increase in PP and SBP between the proximal aorta and peripheral arteries as a consequence of the wave reflection. The difference between central and peripheral arteries depends on age and results in a decrease in pulse amplification. Therefore, the true relative difference in the SV to PP ratio between age groups would probably be much greater than that reported in this study if the PP had been obtained from the aorta.45 An invasive study in the aortic arch, performed primarily in normotensive subjects, found similar trends in SBP, DBP, and SVR over the age range of 20 to 60 years.46 Aortic systolic pressure increased 25% and SVR 37% without changes in aortic DBP. The rise in the characteristic aortic impedance (137%) was much greater than the change in the ratio of SV to PP observed in our noninvasive study. With this exception, the study agrees with ours in that it shows that aortic DBP remains unchanged despite a significant increase in SVR. Thus, it is unlikely that the stable DBP across the age range depended on the anatomic site of BP measurement. Our epidemiological data confirm that auscultatory DBP remains relatively unchanged with age in both normotensive and MMH subgroups (Fig 1BUp). This pattern differs from that observed in the overall population, in which DBP rises until the sixth decade and then decreases after the seventh decade despite a continuous increase in SBP (Fig 1AUp). As shown in Fig 2Up, the increasing number of individuals with diastolic hypertension explains the age-related rise in DBP in the overall population, whereas the increase in the prevalence of BSH and ISH underlies the later fall in DBP.

Clinical-Epidemiological Implications
This study provides confirmatory evidence of the limitations of diastolic pressure to characterize arterial hypertension, especially in the elderly. Because an increase in SVR and a decrease in AC have opposite effects on DBP but an additive effect on SBP, the latter better reflects the underlying circulatory impairment. This finding agrees with morphological studies that describe in older subjects an association between subclinical arteriosclerotic disease and lower DBP and higher SBP.47 48 49 Therefore, as patients get older, DBP becomes progressively less related to vascular resistance. This concept is in contrast to the old clinical management of hypertension based on DBP values and guided by the assumption that vascular resistance is positively related to DBP level, without consideration being given to the patient's age.

As experimental studies suggest, an isolated decrease in AC reduces DBP and increases SBP.5 This change could determine by a reduction in DBP a transition of MMH toward a systolic pattern of hypertension. The size and age ranges of the subjects studied in the present analysis lend support to the hypothesis that the transition in the hypertension pattern from diastolic to systolic may be explained by a change in hemodynamic forces associated with age. The study shows (1) that as mild to moderate hypertensive patients get older, vascular resistance and SBP become higher without change in DBP and (2) that patients with ISH have similar vascular resistance and SBP but lower AC and DBP than older mild to moderate hypertensive patients. On the basis of these findings, it is possible that as patients with MMH get older, DBP decreases below 90 mm Hg.

In addition, in the presence of lower SAC, new hypertensive subjects may emerge as purely systolic despite high SVR, as we documented in BSH and ISH.

This could partially explain why the rise in the prevalence of MMH stops after the sixth decade and is "replaced" by a simultaneous increase in the prevalence of isolated systolic forms of hypertension.

An alternative explanation of why the prevalence of diastolic hypertension tends to be lower with aging is the classic "demographic" interpretation; patients with diastolic hypertension die earlier than patients with ISH because the latter enjoy a better medical condition. However, recent studies have demonstrated that untreated ISH patients are associated with a high rate of morbidity.50 51 The hypothesis that the increase in the prevalence of diastolic hypertension becomes blunted after the sixth decade because of an age-related hemodynamic transition52 is reinforced by the analysis of long-term longitudinal hemodynamic studies.35 53 Examination of the data from the Bergen study shows that those patients aged 17 to 29 years at entry time showed a mild increase in DBP and SBP after 20 years of follow-up. In contrast, the group aged 40 to 49 years at entry showed a transition from the diastolic to the systolic pattern of hypertension. This age-related change in BP pattern at follow-up was associated with a reduction in AC and CI and a rise in vascular resistance.

Furthermore, a recent report documented that a considerable proportion of patients with ISH (treated and untreated) had previous (burned-out) diastolic hypertension.54 Therefore, it is possible that with the passing of time, DBP in some patients could decrease because of worsened circulatory homeostasis instead of a positive response to treatment.

The clinical significance of this observation is reinforced by data from the Multiple Risk Intervention Trial when the relation between mortality from ischemic heart disease and BP parameters are compared at different ages. This study shows that with increasing age, DBP decreases its predictor value for coronary heart disease mortality whereas there is no reduction in the positive relation between ischemic heart disease mortality and SBP with age, and SBP is a stronger predictive factor than DBP in subjects >39 years old.50

In summary, the present results show a simultaneous age-related impairment in vascular resistance and AC in different types of hypertension. These hemodynamic changes could underlie the transition in the prevalence of diastolic and systolic forms of hypertension. Also, our results suggest that SBP, but not DBP, is a reliable indicator of the underlying hemodynamic abnormalities (high resistance and low arterial compliance) in the elderly.


*    Selected Abbreviations and Acronyms
 
AC = arterial compliance
BP = blood pressure
BSH = borderline systolic hypertension
CI = cardiac index
CO = cardiac output
DBP = diastolic blood pressure
ISH = isolated systemic hypertension
MAP = mean arterial pressure
MMH = mild to moderate hypertension
PP = pulse pressure
SAC = systemic arterial compliance
SBP = systolic blood pressure
SV = stroke volume
SVR = systemic vascular resistance
SVRI = systemic vascular resistance index


*    Acknowledgments
 
The authors are grateful to Silvia Yeha for her secretarial assistance.

Received September 9, 1996; first decision October 3, 1996; accepted March 4, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Meserli HF, De Carvalho JGR, Cristie B, Frolich DE. Systemic and regional hemodynamics in low, normal, and high cardiac output. Circulation. 1978;58:441-448.[Free Full Text]

2. Koch-Weser J. Correlation of pathophysiology and pharmacology in primary hypertension. Am J Cardiol. 1973;27:499-510.

3. Bulpitt CJ, Palmer AJ, Fletcher AE, Bradley IC, Beevers G, Coles E, Ledingham JO, Riordan P, Petrie J, Rajagopalan B, Webster J, Dollery C. Relation between treated blood pressure and death from ischaemic heart disease at different ages: a report from the Department of Health Hypertension Care Computing Project. J Hypertens. 1992;10:1273-1278.[Medline] [Order article via Infotrieve]

4. Galarza CR, Waisman G, Alfie J, Vignolo C, Mayorga M, Camera L, Tessler J, Camera M. Diastolic blood pressure underestimates hemodynamic impairment associated to age in mild to moderate hypertension. J Hypertens. 1992;10(suppl 4):S94. Abstract.

5. Randall OS, van Den Bos GC, Westerhof N. Systemic compliance: does it play a role in the genesis of essential hypertension? Cardiovasc Res. 1984;18:455-462.[Medline] [Order article via Infotrieve]

6. Limansky RB, Farías JA, Cámera MI, for the Multicenter Group for the Study of Hypertension and Risk Factors. Arterial hypertension (AH) prevalence in Argentina. J Hypertens. 1992;10(suppl 4):S37. Abstract.

7. 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med.. 1988;148:1023-1038.[Abstract/Free Full Text]

8. Alfie J, Waisman G, Galarza CR, Magi M, Vasvari F, Mayorga LM, Cámera MI. Relationship between systemic hemodynamics and ambulatory blood pressure level are sex dependent. Hypertension. 1995;26(part 2):1195-1199.

9. Kubicek WG, Kottke FJ, Ramos MU, Patterson RP, Witsoe DA, Labree JW, Remole W, Layman TE, Schoening H, Garamella JT. The Minnesota impedance cardiograph theory and applications. Biomed Eng. 1974;9:410-416.[Medline] [Order article via Infotrieve]

10. Ebert TJ, Eckerg DL, Vetrovec GM, Cowley MJ. Impedance cardiograms reliably estimate beat by beat changes of left ventricular stroke in humans. Cardiovasc Res. 1984;18:354-360.[Medline] [Order article via Infotrieve]

11. Veigl VL, Judy WV. Reproducibility of haemodynamic measurements by impedance cardiography. Cardiovasc Res. 1983;17:728-734.[Medline] [Order article via Infotrieve]

12. Gotshall RW, Wood VC, Miles DS. Comparison of two impedance cardiographic techniques for measuring cardiac output. Ann Biomed Eng. 1989;17:495-504.[Medline] [Order article via Infotrieve]

13. Quail AW, Traugott FM, Porges WL, White SW. Thoracic resistivity for stroke volume calculation in impedance cardiography. J Appl Physiol. 1981;50:191-195.[Abstract/Free Full Text]

14. Tarazi RC. The hemodynamics of hypertension. In: Genest J, Kuchel O, Hamet P, Cartin M, eds. Hypertension, Physiopathology, and Treatment. 2nd ed. New York, NY: McGraw Hill Book Inc; 1983:15-41.

15. Madkour MA, Levenson J, Bravo E, Simon A, Fouad-Tarazi F. Preload, adrenergic activity, and aortic compliance in normal and hypertensive patients. Am Heart J. 1989;118:1243-1247.[Medline] [Order article via Infotrieve]

16. Ventura H, Messerli F, Oigman W, Suarez D, Dreslinski GR, Dunn FG, Reisin E, Frohlich ED. Impaired systemic arterial compliance in borderline hypertension. Am Heart J. 1984;108:132-136.[Medline] [Order article via Infotrieve]

17. Gudbrandsson T, Julius S, Krause L, Jamerson K, Randall OS, Schork N, Weder A. Correlate of the estimated arterial compliance in the population of Tecumseh, Michigan. Blood Press. 1992;1:27-34.[Medline] [Order article via Infotrieve]

18. Ferguson JJ, Randall O. Hemodynamic correlates of arterial compliance. Cather and Cardiovasc Diagn. 1986;12:376-380.

19. Randall O, Westerhof N, van Den Bos G, Alexander B. Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance. J Hypertens. 1986;4(suppl 5):S293-S296.

20. Liu Z, Ting CT, Yin FCP. Aortic compliance in human hypertension. Hypertension. 1989;14:129-136.[Abstract/Free Full Text]

21. Galarza CR, del Rio M. Cardiografía por impedancia en la evaluación de la función cardiovascular. In: del Rio M, Romero JC, eds. Función Cardiovascular. Buenos Aires, Argentina: Propulsora Literaria; 1992:220-237.

22. Teo KK, Hetherington MD, Haennel RG, Greenwood PV, Rossall RE, Kappagoda T. Cardiac output measured by impedance cardiography during maximal exercise tests. Cardiovasc Res. 1985;19:737-743.[Medline] [Order article via Infotrieve]

23. Appel PL, Kram HB, Mackabee J, Fleming AW, Shoemaker WC. Comparison of measurements of cardiac output by bioimpedance and thermodilution in severely ill surgical patients. Crit Care Med. 1986;14:933-935.[Medline] [Order article via Infotrieve]

24. Edmunds AT, Godfrey S, Tooley M. Cardiac output measured by transthoracic impedance cardiography at rest, during exercise, and at various lung volumes. Clin Sci. 1982;63:107-113.[Medline] [Order article via Infotrieve]

25. Mehlsen J, Bonde J, Stadeager C, Rehling M, Tango M, Trapjensen J. Reliability of impedance cardiography in measuring central haemodynamics. Clin Physiol. 1982;11:579-588.

26. Muzi A, Ebert TJ, Tristani FE. Determination of cardiac output using ensemble-averaged impedance cardiograms. J Appl Physiol. 1985;41:200-205.

27. Pepke-Zaba J, Higenbottam TW, Dinh Xuan AT, Scott JP, English TA, Wallwork J. Validation of impedance cardiography measurements of cardiac output during limited exercise in heart transplant recipients. Transpl Int. 1990;3:108-112.[Medline] [Order article via Infotrieve]

28. Denniston JC, Maher RT, Reeves JC, Cruz A, Cymerman A, Grover RF. Measurement of cardiac output by electrical impedance at rest and during exercise. J Appl Physiol. 1976;40:91-95.[Abstract/Free Full Text]

29. Ovsyshcher Y, Gross JN, Blumerg S, Adrews C, Ritacco R, Furman S. Variability of cardiac output as determined by impedance cardiography in pacemaker patients. Am J Cardiol. 1993;72:183-187.[Medline] [Order article via Infotrieve]

30. Galarza CR, Waisman G, Alfie J, del Rio M, Mayorga M, Magi M, Vignolo C, Camera L, Tessler J, Camera M. Variabilidad del índice de descarga sistólica (IDS) e índice cardíaco (IC) estimados con cardiografia de impedancia (CI) en hipertensos leves tratados con placebo (PBO) durante un mes. Medicina. 1991;51:398. Abstract.

31. Galarza CR, Waisman G, Mayorga LM, Vignolo C, Tessler J, Camera M. Alta reproducibilidad intra e interensayo del volumen minuto cardiaco y de la descarga sistolica estimados con cardiografia de impedancia. Rev Arg Cardiol. 1991;59:312. Abstract.

32. Adamopoulos PN, Chrysanthakopoulis SG, Frohlich ED. Systolic hypertension: nonhomogeneous diseases. Am J Cardiol. 1975;36:697-701.[Medline] [Order article via Infotrieve]

33. Fagard R, Staessen J. Relation of cardiac output at rest and during exercise to age in essential hypertension. Am J Cardiol. 1991;67:585-589.[Medline] [Order article via Infotrieve]

34. Birkenhager WH, Schalekamp MADH, Krauss XH, Kolters G, Zaal GA. Consecutive haemodynamic patterns in essential hypertension. Lancet. 1992;11:560-564.

35. Lund-Johansen P. The hemodynamics of the aging cardiovascular system. J Cardiovasc Pharmacol. 1988;12(suppl 8):S20-S30.

36. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, O'Rourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation. 1985;71:202-210.[Abstract/Free Full Text]

37. Simon AC, Safar M, Levenson JA, Kheder AM, Levy B. Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment. Am J Cardiol. 1979;44:505-511.[Medline] [Order article via Infotrieve]

38. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertens. 1992;10(suppl 6):S73-S77.

39. Berger D, Li JK. Concurrent compliance reduction and increased peripheral resistance in the manifestation of isolated systolic hypertension. Am J Cardiol. 1990;65:67-71.[Medline] [Order article via Infotrieve]

40. Sunagawa K, Burkhoff D, Lim K, Sagawa K. Impedance loading servo pump system for excised canine ventricle. Am J Physiol. 1982;12:H346-H350.

41. Elzinga G, Westerhof N. Pressure and flow generated by the left ventricle against different impedances. Circ Res. 1973;32:178-186.[Abstract/Free Full Text]

42. Cristensen K. Reducing pulse pressure in hypertension may normalize small artery structure. Hypertension. 1991;18:722-727.[Abstract/Free Full Text]

43. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995;26:301-306.[Abstract/Free Full Text]

44. Abergel E, Chatellier G, Toussaint P, Dib JC, Menard J, Diebold B. Doppler-derived pulmonary arterial systolic pressure in patients with known systemic arterial pressures. Am J Cardiol. 1996;77:765-769.[Medline] [Order article via Infotrieve]

45. O'Rourke MO, Kelly R, Avolio A, eds. The Arterial Pulse. Philadelphia, Pa: Lea & Febiger; 1992:1-239.

46. Nichols WW, O'Rourke MF, Avolio AP, Yaginuma T, Murgo JP, Pepine CJ, Conti CR. Effects of age on ventricular-vascular coupling. Am J Cardiol. 1985;55:1179-1184.[Medline] [Order article via Infotrieve]

47. Psaty B, Furberg C, Kuller L. Hipertension sistolica aislada y enfermedad cardiovascular subclinica en la tercera edad. JAMA (Ed Española). 1992;268:1287-1291.

48. Witteman JC, Grobbee DE, Vakenburg HA, van Hemert M, Stinjen T, Burger H, Hofman A. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504-507.[Medline] [Order article via Infotrieve]

49. Bots ML, Witteman JCM, Hofman A, deJong PTVM, Grobbee DE. Low diastolic blood pressure and atherosclerosis in elderly subjects: the Rotterdam Study. Arch Intern Med. 1996;156:843-848.[Abstract/Free Full Text]

50. Neaton JD, Wentworth F, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch Intern Med. 1992;152:56-64.[Abstract/Free Full Text]

51. SHEP Cooperative Research Group (1991). Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.[Abstract/Free Full Text]

52. Galarza CR, Alfie J, Waisman G, Mayorga M, Magi M, Cámera MI. Could be isolated systolic hypertension an evolutive variant of mild to moderate hypertension? An epidemiological and hemodynamic approach. Sixth European Meeting on Hypertension; June 1993; Milan, Italy. Abstract 246.

53. Mo R, Omvik P, Lund-Johansen P. The Bergen Blood Pressure Study: blood pressure changes, target organ damage and mortality in subjects with high and low blood pressure over 27 years. Blood Press. 1993;2:113-123.[Medline] [Order article via Infotrieve]

54. Bulpitt CJ, Palmer AJ, Fletcher AE, Bradley IC, Broxton JC, Davis AJ, Ganvir PL, Gostik NK, Mayhew SR, Mujerki D, Sheperd FS, Well FO. Proportion of patients with isolated systolic hypertension who have burned out diastolic hypertension. J Hum Hypertens. 1995;9:675-678.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
HypertensionHome page
Y. Suwazono, M. Dochi, K. Sakata, Y. Okubo, M. Oishi, K. Tanaka, E. Kobayashi, and K. Nogawa
Shift Work Is a Risk Factor for Increased Blood Pressure in Japanese Men: A 14-Year Historical Cohort Study
Hypertension, September 1, 2008; 52(3): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
C. M. Ferrario, J. Basile, W. Bestermann, E. Frohlich, M. Houston, D. T. Lackland, R. D. Smith, and D. L. Wise
Review: The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertension
Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 113 - 118.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. M. Jimenez, C. Conde, A. Casanegra, C. Romero, A. Hugo Tabares, and M. Orias
Association of ACE genotype and predominantly diastolic hypertension: a preliminary study
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 42 - 44.
[Abstract] [PDF]


Home page
HypertensionHome page
J. Alfie, G. D. Waisman, C. R. Galarza, and M. I. Camera
Contribution of Stroke Volume to the Change in Pulse Pressure Pattern With Age
Hypertension, October 1, 1999; 34(4): 808 - 812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Segers, N. Stergiopulos, and N. Westerhof
Relation of effective arterial elastance to arterial system properties
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1041 - H1046.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galarza, C. R.
Right arrow Articles by Cámera, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galarza, C. R.
Right arrow Articles by Cámera, M. I.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Seniors' Health